Chronobiology International is the journal of biological and medical rhythm research. It is a transdisciplinary journal focusing on biological rhythm phenomena of all life forms. The journal publishes groundbreaking articles plus authoritative review papers, short communications of work in progress, case studies, and letters to the editor, for example, on genetic and molecular mechanisms of insect, animal and human biological timekeeping, including melatonin and pineal gland rhythms. It also publishes applied topics, for example, shiftwork, chronotypes, and associated personality traits; chronobiology and chronotherapy of sleep, cardiovascular, pulmonary, psychiatric, and other medical conditions. Articles in the journal pertain to basic and applied chronobiology, and to methods, statistics, and instrumentation for biological rhythm study.
Journal metrics
Usage
351K annual downloads/views
Citation metrics
2.2 (2023) Impact Factor
Q2 Impact Factor Best Quartile
3.1 (2023) 5 year IF
5.6 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.815 (2023) SNIP
0.830 (2023) SJR
Speed/acceptance
32 days avg. from submission to first
decision
92 days avg. from submission to first
post-review decision
11 days avg. from acceptance to online
publication
39% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Editor-in-Chief R. Refinetti - University of New Orleans, New Orleans, Louisiana, USA Email: [email protected]
Associate Editors A. Gall - Hope College, Holland, Michigan, USA H. Wang - Soochow University, Suzhou, China G. Zerbini - Augsburg University, Augsburg, Germany
Editorial Board T. Akerstedt – IPM/Karolinska Institute, Stockholm, Sweden U. Albrecht – Department of Biology, University of Fribourg, Fribourg, Switzerland J. F. Araujo – Departamento de Fisiologia e Comportamento, Universidade Federal do Rio Grande do Norte, Natal, Brazil H. Balan – Clinical Internal Medicine, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania C. Bartsch – Interfaculty Institute of Biochemistry, University of Tuebingen, Tuebingen, Germany D. Boivin – Center for Study and Treatment of Circadian Rhythms, McGill University, Montreal, Canada T. Cambras – Department of Physiology, University of Barcelona, Barcelona, Spain R. C. Castriotta – Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA G. Cornelissen-Guillaume – Integrative Biology/Physiology & Halberg Chronobiology Center, Medical School, University of Minnesota, Minneapolis, Minnesota, USA Y. Dagan – Applied Chronobiology Research Institute, Tel Hai Academic College, Tel Aviv, Israel S. J. Davis – Department of Biology, University of York, York, UK O. Dkhissi-Benyahya – SBRI, CRCN–INSERM, Lyon, France M. Doi – Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan G. E. Duffield – Department of Biological Sciences, University of Notre Dame, Notre Dame,Indiana, USA J. Elliott – Center for Circadian Biology, University of California San Diego, La Jolla, California, USA C. Escobar – Department of Anatomy, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico F. Fischer – Department of Environmental Health, School of Public Health, University of São Paulo, São Paulo, Brazil J. R. Fernández – atlanTTic Research Center, University of Vigo, Vigo, Spain R. Foster – Sleep & Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK A. Fujimura – Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan S. Gaddameedhi – Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA Y.-J. Geng – Cardiology, Department of Internal Medicine, McGovern School of Medicine, The University of Texas-Houston, Houston, Texas, USA N. Goel – Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA D. Golombek – Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes/CONICET, Buenos Aires, Argentina M. Hébert – Faculty of Medicine, Université Laval, Quebec, Canada R. Hermida – atlanTTic Research Center, University of Vigo, Vigo, Spain K. S. Jankowski – Faculty of Psychology, University of Warsaw, Warsaw, Poland S. Kiessling – Technical University of Munich, Munich, Germany B. Lemmer – Institute of Pharmacology and Toxicology, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany F. Levi – Cancer Chronotherapy Team, Division of Biomedical Sciences and Cancer Research Centre, Warwick Medical School, Warwick University, Coventry, UK H. Li – Sichuan International Studies University, Sichuan, China J. A. Madrid – Department of Physiology, Faculty of Biology, University Murcia, IMIB-Arrixaca, Murcia, Spain & CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain J. Mendoza – Institut des Neurosciences Cellulaires et Intégratives, Université de Strasbourg, Strasbourg, France L. S. Menna Barreto – Escola de Artes, Ciências e Humanidades, Universidade de São Paulo, São Paulo, Brazil R. Mistlberger – Department of Psychology, Simon Fraser University, Burnaby, Canada H. Oster – Center of Brain, Behavior & Metabolism, University of Lübeck, Luebeck, Germany G. Piccione – School of Veterinary Medicine, University of Messina, Messina, Italy G. N. Pires – Federal University of São Paulo, São Paulo, Brazil M. Riedel – Center for Chronobiology Research, Fondation A. de Rothschild, Paris, France F. A. J .L. Scheer – Departments of Medicine and Neurology, Brigham & Women's Hospital, Boston, Massachusetts, USA A. Silva – Laboratorio de Neurociencias, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay D. J. Skene – Chronobiology, University of Surrey, Guilford, UK J. H. Stehle – Institute of Anatomy, Goethe University Frankfurt, Frankfurt, Germany M. Stolarski – University of Warsaw, Warsaw, Poland Y. Touitou – Center for Chronobiology Research, Fondation A. de Rothschild, Paris, France E. J. W. Van Someren – Department of Sleep & Cognition, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands D. Weinert – Institute of Biology/Zoology, Martin Luther University Halle-Wittenberg, Halle, Germany M. Young – Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
Updated 17-01-2024
Open access
Chronobiology International is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Sports and Leisure journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110824/Subject-Sample-2021-Sports-Leisure.jpg"})
![Gates Open Research is a platform for rapid author-led publication and open peer review of research funded by the Bill & Melinda Gates Foundation.]({"type":"image" , "src" : "/sda/112431/GATES-KB.jpg"})